查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球关节内置换疗法市场
市场调查报告书
商品编码
1153812

2022-2029 年全球关节内置换疗法市场

Global Viscosupplementation Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球关节内置换疗法的市场规模预计在 2022 年达到 453867 万美元，在 2029 年达到 805834 万美元，预测期内（2022-2029 年）的复合年增长率为 8.96%。据说会增长在

关节内置换疗法是一种微创手术，其中将有助于滑液粘性的凝胶状物质注入关节。旨在改善关节病患者的关节功能。透明质酸增加滑液的润滑性，减轻膝骨关节炎的疼痛，并改善运动功能。

市场动态

骨关节炎和类风湿性关节炎发病率的上升、研究和开发的增加以及对缓解疼痛的关节内替代疗法的需求不断增加是推动全球关节内替代疗法市场的主要因素。它是

骨关节炎患病率和发病率的上升以及技术的不断进步预计将推动市场增长。

关节内替代疗法市场受到技术进步、研究和开发增加以及骨关节炎关节内替代疗法的高需求的推动，这也有望推动关节内替代疗法市场。它有到过。市场增长也归因于医疗保健和临床试验支出的增加。此外，预计主要製造商提供的技术先进的产品也将在市场增长中发挥重要作用。

增加政府补贴和提高对骨关节炎治疗的认识将促进市场增长。关节内替代疗法在骨关节炎疼痛管理中的高采用率也是关节内替代疗法市场的驱动因素之一。各种新产品的发布和研究正在为市场的增长做出贡献。

例如，2021 年 8 月，Seikagaku Corporation 从台湾 TCM Biotech International Corporation 推出了 Hilink，这是一种用于治疗膝骨关节炎的单次注射关节内替代疗法。这款HYLINK主要由生化学的交联技术製成的交联透明质酸水凝胶组成，用于治疗膝骨关节炎。具有高粘弹性的透明质酸水凝胶有望通过长期停留在膝关节腔内来改善症状。

与关节内置换疗法相关的副作用预计会阻碍市场增长。

然而，使用关节内替代疗法的副作用，例如肿胀和瘙痒、关节周围瘀伤以及注射膝关节积液，正在阻碍全球关节内替代疗法市场的增长。

COVID-19 影响分析

疫情对全球金融预期、运营和危机应对策略产生了负面影响。 COVID-19 的爆发严重影响了医疗保健行业。由于 COVID 病例的增加，各种研究和临床试验被推迟，关节内替代治疗市场因 COVID 遭受了巨大损失。世界各地正在发生各种倡议、合作和合併，促进了市场的增长。例如，2021 年 12 月，Avanos Medical, Inc. 宣布达成协议，以约 1.6 亿美元的价格收购 OrthogenRx Inc.，后者是膝关节骨性关节炎疼痛的关节内替代疗法供应商。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 骨关节炎的患病率和发病率上升
      • 技术进步的增加
    • 约束因素
      • 相关副作用
    • 市场机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 流行病学

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按程序类型

  • 单次注射
  • 3 次注射
  • 5 注射

第八章应用

  • 膝盖骨关节炎
  • 髋骨关节炎
  • 肩骨关节炎
  • 脚踝骨关节炎

第 9 章最终用户

  • 骨科诊所
  • 医院
  • 门诊手术中心

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • Anika Therapeutics, Inc.
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Seikagaku Corporation
  • Bioventus Inc.
  • Johnson and Johnson
  • Zimmer Biomet
  • Sanofi S.A.
  • Miravo Healthcare
  • Aptissen
  • L.G. Chem and Lifesciences Ltd
  • F. Hoffmann La Roche

第13章 全球关节内置换疗法市场-DataM

简介目录
Product Code: DMPH1188

Market Overview

The global viscosupplementation market size was valued at US$ 4,538.67 million in 2022 and is estimated to reach US$ 8,058.34 million by 2029, growing at a CAGR of 8.96% during the forecast period (2022-2029).

Viscosupplementation is a minimally invasive procedure that involves the injection of gel-like substances into a joint to assist the viscous properties of synovial fluid in reducing the joint pain and improves the functional condition of osteoarthritis joints by using a thick fluid called hyaluronate is injected into the knee joint. Hyaluronate helps improve the lubricating properties of the synovial fluid, reduces the pain from osteoarthritis of the knee, and improves mobility.

Market Dynamics

The rising incidence of osteoarthritis and rheumatoid arthritis, increasing research and development, and rising demand for viscosupplementation for relieving pain are the major factors driving the global viscosupplementation market.

The rising prevalence & incidence of osteoarthritis and increasing technological advancements are expected to drive the market's growth.

The viscosupplementation market is driven by rising technological advancements, increasing research & development, and high demand for viscosupplementation in osteoarthritis, which is also expected to drive the viscosupplementation market. The market's growth can also be attributed to the rising expenditure on healthcare and clinical trials. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Rising government funding and increasing awareness of treating osteoarthritis will boost market growth. Another driving factor for the viscosupplementation market is the high adoption rate of viscosupplementation for osteoarthritis pain management. Various novel product launches and research studies contribute to the market's growth.

For instance, in Aug 2021, Seikagaku Corporation launched its Hylink, an intra-articular viscosupplement single injection for knee osteoarthritis treatment in Taiwan, by TCM Biotech International Corporation. This HyLink is used for knee osteoarthritis treatment as its main ingredient, cross-linked hyaluronate hydrogel, is made by crosslinking technology of Seikagaku. It is expected to show improvement in symptoms as highly viscoelastic hyaluronate hydrogel will remain in the joint cavity of the knee for a longer duration.

Side effects associated with viscosupplementation are expected to hamper market growth.

However, the side effects of using viscosupplementation, like swelling, itching, bruising around the joint, and fluid accumulation in the injected knee, hamper the global viscosupplementation market growth.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The Viscosupplementation market has experienced huge losses due to COVID, as various research and clinical trials got postponed due to the increasing cases of COVID. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Dec 2021, Avanos Medical, Inc. announced about its agreement to acquisition with OrthogenRx Inc., a viscosupplementation therapies provider for knee osteoarthritis pain, for around $160 million.

Segment Analysis

The knee osteoarthritis segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Knee osteoarthritis is a joint disorder that is slowly progressive that can be characterized by cartilage degeneration, joint pain, and inflammation; that affects around 350 million people globally. Knee osteoarthritis has various treatment options, from conservative management to knee arthroplasty. The most used non-operative therapies are intra-articular therapies like hyaluronic acid and corticosteroids. This intra-articular hyaluronic acid is the widely used therapy for treating knee pain and inflammation in people with knee osteoarthritis.

The knee osteoarthritis segment dominates the market due to rising global incidences of knee osteoarthritis and the increasing geriatric population. The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in Sep 2021, Bioventus Inc., an active healing innovation company, announced that the American Academy of Orthopaedic Surgeons released their updated clinical practice guidelines that show that Bioventus's DUROLANE treatment and all the high molecular weight cross-linked hyaluronic treatments have shown improvement in patients with knee osteoarthritis.

Geographical Analysis

North America holds the largest market share in the global viscosupplementation market.

North America dominates the global viscosupplementation market, primarily attributed to the rising number of people suffering from osteoarthritis. According to the Centre for Disease Control and Prevention, in 2020, over 32.5 million adults were dealing with osteoarthritis in the United States. Around 14 million people are suffering from rheumatoid arthritis globally. Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. Advancement of technology in these viscosupplementations, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the viscosupplementation market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Jul 2022, Bioventus Inc., an active healing innovative company, announced its completion of the acquisition of CartiHeal. This acquisition adds CartHeal's active healing solutions portfolio to Bioventus.

Competitive Landscape

The viscosupplementation market is moderately competitive with local and global companies' presence. Anika Therapeutics, Inc., Seikagaku Corporation, Bioventus Inc., Johnson and Johnson, Zimmer Biomet, Sanofi S.A., Miravo Healthcare, Aptissen, L.G. Chem and Lifesciences Ltd, F. Hoffmann La Roche and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2021, Bioventus Inc., an active healing innovator company, announced the completion of the acquisition of Misonix Inc., regenerative medicine and minimally invasive therapeutic ultrasonic technologies provider developed for better clinical outcomes.

Anika Therapeutics Inc.

Overview: Anika Therapeutics is a company of joint preservation that provides a variety of advancements in orthopedic care early intervention. They provide solutions for soft tissue repair, osteoarthritis pain management, bone-preserving joint technologies, and regenerative therapeutics.

Product Portfolio:

Cingal: This is the first combination viscosupplement approved that provides both cross-linked hyaluronic acid as well as fast-acting steroid advantages for the treatment of osteoarthritis-associated symptoms. It combines Anika's Monovisc HA formulation with triamcinolone hexacetonide, an FDA-approved steroid for treating inflammation and relieving pain.

Key Development: In Jan 2020, Anika Therapeutics Inc., an integrated company of regenerative therapies and joint preservation with products supporting its hyaluronic acid technology platform, announced its acquisition agreement with Parcus Medical, a company of sports medicine and Arthrosurface, a solution provider for joint surface and preservation.

The global viscosupplementation market report would provide access to approx. 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising prevalence & incidence of osteoarthritis
      • 4.1.1.2. Increasing technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Associated Adverse Effects
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis
  • 5.5 Epidemiology

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Procedure Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 7.1.2. Market Attractiveness Index, By Procedure Type
  • 7.2. Single Injection *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Three Injection
  • 7.4. Five Injection

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Knee Osteoarthritis *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Hip Osteoarthritis
  • 8.4. Shoulder Osteoarthritis
  • 8.5. Ankle Osteoarthritis

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Orthopedic Clinics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Hospitals
  • 9.4. Ambulatory Surgical Centres

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Anika Therapeutics, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Seikagaku Corporation
  • 12.3. Bioventus Inc.
  • 12.4. Johnson and Johnson
  • 12.5. Zimmer Biomet
  • 12.6. Sanofi S.A.
  • 12.7. Miravo Healthcare
  • 12.8. Aptissen
  • 12.9. L.G. Chem and Lifesciences Ltd
  • 12.10. F. Hoffmann La Roche

LIST NOT EXHAUSTIVE

13. Global Viscosupplementation Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us